BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
64 hedge funds and large institutions have $376M invested in BELLUS Health Inc. in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
33% more funds holding
Funds holding: 48 → 64 (+16)
13% more capital invested
Capital invested by funds: $334M → $376M (+$42.2M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$15.7M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$15.6M |
| 3 |
PA
Perceptive Advisors
New York
|
+$11.4M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$9.68M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$7.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$19.1M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$16M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.99M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$5.44M |
| 5 |
First Manhattan
New York
|
-$4.08M |
BLU Hedge Fund Activity: Q2 2020 in Review
64 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q2 2020, worth a combined $376M — up 13% from $334M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new BLU positions and 8 closed out — a net gain of 16 holders — while 20 added to existing stakes and 12 trimmed.
The largest buyer was Cowen and Company, adding an estimated $15.7M. The largest seller was OrbiMed, cutting an estimated $19.1M.
- 64 institutional investors held BELLUS Health Inc. (BLU) as of Q2 2020, up from 48 in Q1 2020.
- Funds reported $376M of BELLUS Health Inc. stock for Q2 2020, up 13% quarter-over-quarter.
- 24 funds opened new BELLUS Health Inc. positions in Q2 2020 and 8 closed out, a net change of +16 holders.
- The largest BELLUS Health Inc. buyer in Q2 2020 was Cowen and Company, an estimated $15.7M added.
- The largest BELLUS Health Inc. seller in Q2 2020 was OrbiMed, an estimated $19.1M sold.
Based on aggregated 13F filings for Q2 2020.